Inventor profile of:

Jorge E. Osorio

City:

Mount Horeb, Wisconsin

Country:

United States

Published Applications:

27

Last publication date:

2024-09-26

Top Assignees for applications by Jorge E. Osorio

The entities that hold a legal rights for patent applications filed by inventor Osorio Jorge E.:

Recent patent applications by Osorio Jorge E.

Jorge E. Osorio from Mount Horeb, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-09-26
US20240316185A1
Human necessities

CORONAVIRUS VACCINE COMPRISING A MOSAIC PROTEIN

#2 | 2023-08-17
US20230256087A1
Human necessities

Coronavirus vaccine comprising a mosaic protein

#3 | 2022-04-21
US20220118074A1
Human necessities

ZIKA VIRUS VACCINES USING VIRUS-LIKE PARTICLES

#4 | 2020-04-09
US20200108136A1
Human necessities

Methods and compositions for live attenuated viruses

#5 | 2018-08-16
US20180228887A1
Human necessities

COMPOSITIONS, METHODS OF ADMINISTRATION AND USES FOR TRIVALENT DENGUE VIRUS FORMULATIONS

#6 | 2018-07-05
US20180187165A1
Chemistry; metallurgy

Hand, foot, and mouth vaccines and methods of manufacture and use thereof

#7 | 2018-05-10
US20180125965A1
Human necessities

Hand, foot, and mouth vaccines and methods of manufacture and use thereof

#8 | 2018-02-01
US20180028643A1
Human necessities

ZIKA VIRUS VACCINES USING VIRUS-LIKE PARTICLES

#9 | 2018-01-11
US20180008691A1
Human necessities

COMPOSITIONS AND METHODS FOR RAPID IMMUNIZATION AGAINST DENGUE VIRUS

#10 | 2017-04-13
US20170100474A1
Human necessities

Methods and compositions for live attenuated viruses

#11 | 2016-05-12
US20160129104A1
Human necessities

Hand, foot, and mouth vaccines and methods of manufacture and use thereof

#12 | 2016-05-12
US20160129102A1
Human necessities

Compositions and methods for administration of vaccines against dengue virus

#13 | 2015-12-10
US20150352202A1
Human necessities

Broadly reactive mosaic peptide for influenza vaccine

#14 | 2015-12-03
US20150343046A1
Human necessities

COMPOSITIONS, METHODS AND USES FOR EXPRESSION OF ENTEROBACTERIUM-ASSOCIATED PEPTIDES

#15 | 2015-11-26
US20150335727A1
Human necessities

Compositions, methods of administration and uses for trivalent dengue virus formulations

#16 | 2015-09-03
US20150246109A1
Human necessities

COMPOSITIONS, METHODS AND USES FOR POXVIRUS ELEMENTS IN VACCINE CONSTRUCTS AGAINST INFLUENZA VIRUS SUBTYPES OR STRAINS

#17 | 2015-07-02
US20150184198A1
Chemistry; metallurgy

COMPOSITIONS, METHODS AND USES FOR POXVIRUS ELEMENTS IN VACCINE CONSTRUCTS

#18 | 2015-06-04
US20150150961A1
Human necessities

Compositions and methods for rapid immunization against dengue virus

#19 | 2014-10-09
US20140302091A1
Human necessities

METHODS AND COMPOSITIONS FOR LIVE ATTENUATED VIRUSES

#20 | 2014-09-25
US20140286981A1
Human necessities

BROADLY REACTIVE MOSAIC PEPTIDE FOR INFLUENZA VACCINE

#21 | 2013-08-15
US20130209513A1
Chemistry; metallurgy

Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains

#22 | 2013-06-13
US20130149338A1
Human necessities

Compositions and methods for rapid immunization against dengue virus

#23 | 2013-05-30
US20130136767A1
Chemistry; metallurgy

Compositions, methods and uses for poxvirus elements in vaccine constructs

#24 | 2013-02-07
US20130034583A1
Human necessities

Compositions, methods and uses for expression of enterobacterium-associated peptides

#25 | 2012-01-05
US20120003263A1
Human necessities

RECOMBINANT RACCOON POX VIRUS VACCINE AGAINST HIGHLY PATHOGENIC AVIAN INFLUENZA

#26 | 2010-12-02
US20100303860A1
Human necessities

Compositions and methods for administration of vaccines against dengue virus

#27 | 2008-10-09
US20080248551A1
Human necessities

Methods and compositions for live attenuated viruses

InventorID:

78179 ⎘